Commure

At a $7B valuation and substantial deployment scale, Commure is a major test of whether AI-native platforms can cross from point solutions into full-stack RCM and practice operations.

Raised $70M at $7B post-money valuation led by General Catalyst

Raised $200M growth financing from General Catalyst Customer Value Fund

AI platform targeting autonomous end-to-end RCM at scale, with 85% autonomous claim processing as the stated benchmark. ARR exceeded $200M as of mid-2025. Explicitly positions as a BPO displacement play — the $7B valuation at this round signals investor conviction that AI-native RCM operators can replace outsourced billing vendors.

Commure secured $200 million in growth financing from General Catalyst's Customer Value Fund to accelerate its AI platform across revenue cycle management, ambient clinical documentation and practice management.

Commure completed its all-cash acquisition of Augmedix, taking the ambient AI documentation company private as a wholly owned subsidiary. The announced equity value was approximately $139 million.